When a drug developer loses a partner, there's actually a 50-50 chance that the drug will remain in development, according to a new study of deals data from Informa’s Strategic Transactions . And of
IN VITRO DIAGNOSTICS Mergers & Acquisitions Institut Merieux bioMerieux SA BioFire Diagnostics Inc. Leading diagnostics firm bioMerieux SA (a division of Institut Merieux ) has agreed to acquir